Your browser doesn't support javascript.
loading
Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer.
Luque, Melani; Sanz-Álvarez, Marta; Santamaría, Andrea; Zazo, Sandra; Cristóbal, Ion; de la Fuente, Lorena; Mínguez, Pablo; Eroles, Pilar; Rovira, Ana; Albanell, Joan; Madoz-Gúrpide, Juan; Rojo, Federico.
Afiliación
  • Luque M; Department of Pathology, Fundación Jiménez Díaz University Hospital Health Research Institute (IIS-FJD, UAM)-CIBERONC, 28040 Madrid, Spain.
  • Sanz-Álvarez M; Department of Pathology, Fundación Jiménez Díaz University Hospital Health Research Institute (IIS-FJD, UAM)-CIBERONC, 28040 Madrid, Spain.
  • Santamaría A; Department of Pathology, Fundación Jiménez Díaz University Hospital Health Research Institute (IIS-FJD, UAM)-CIBERONC, 28040 Madrid, Spain.
  • Zazo S; Department of Pathology, Fundación Jiménez Díaz University Hospital Health Research Institute (IIS-FJD, UAM)-CIBERONC, 28040 Madrid, Spain.
  • Cristóbal I; Translational Oncology Division, OncoHealth Institute, Health Research Institute-Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain.
  • de la Fuente L; Genetics Department, Health Research Institute-Fundación Jiménez Díaz (IIS-FJD, UAM), Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, 28040 Madrid, Spain.
  • Mínguez P; Genetics Department, Health Research Institute-Fundación Jiménez Díaz (IIS-FJD, UAM), Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, 28040 Madrid, Spain.
  • Eroles P; Institute of Health Research INCLIVA-CIBERONC, 46010 Valencia, Spain.
  • Rovira A; Department of Physiology, University of Valencia, 46010 Valencia, Spain.
  • Albanell J; Cancer Research Program, IMIM (Hospital del Mar Research Institute), 08003 Barcelona, Spain.
  • Madoz-Gúrpide J; Medical Oncology Department, Hospital del Mar-CIBERONC, 08003 Barcelona, Spain.
  • Rojo F; Cancer Research Program, IMIM (Hospital del Mar Research Institute), 08003 Barcelona, Spain.
Int J Mol Sci ; 22(24)2021 Dec 10.
Article en En | MEDLINE | ID: mdl-34948097
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Sistemas de Liberación de Medicamentos / Receptor ErbB-2 / Resistencia a Antineoplásicos / Fibroblastos Asociados al Cáncer Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Sistemas de Liberación de Medicamentos / Receptor ErbB-2 / Resistencia a Antineoplásicos / Fibroblastos Asociados al Cáncer Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: España